KIMBERLY-CLARK PROFESSIONAL*
KIMBERLY-CLARK PROFESSIONAL* announces the latest in contamination control for sterile environments: the KIMTECH PURE* M3 Sterile Pouch Facemask, designed for maximum bacterial and particle filtration.
New sterile pouch-style cleanroom mask provides superior breathability, comfort and airflow
KIMBERLY-CLARK PROFESSIONAL* announces the latest in contamination control for sterile environments: the KIMTECH PURE* M3 Sterile Pouch Facemask. The facemask is recommended for use in ISO Class 5 or higher cleanrooms.
The mask’s pouch design and large breathing chamber reduce the chance for particle build-up. Its consistently tight seal helps to reduce goggle fogging and the risk of escaping particles.
“A protective, comfortable facemask means better performance,” explains Jamie Cassar, Category manager, KIMBERLY-CLARK PROFESSIONAL* EMEA. “And better performance means better protection, which is important in sterile environments that require constant monitoring to prevent contamination.”
The mask’s two knitted headbands are comfortable and help to hold the mask in place while it’s being worn. Additional comfort is provided by the mask’s fabric inner facing.
Made of apertured, low-lint polyethylene film for protection against contamination, the KIMTECH PURE* M3 Sterile Pouch Facemask contains no natural rubber latex, thus reducing the risk of allergic reactions. The masks are individually packaged and triple-bagged for extra protection. They are gamma irradiated with a Sterility Assurance Level (SAL) of 10-6. Certificates of Irradiation are available online at www.kimtech.com/certificates.
For further information, please send an e-mail to Kimtech.support@kcc.com or visit www.contaminomics.com.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
